Conclusion
The observed positive correlation between high VEGF levels and clinical complaints may indicate that VEGF may be involved in development of chronic conditions related to Y. enterocolitica infection. Further studies are required to elucidate the possible connection between VEGF, IgA, and chronic sequels of infectious diseases.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dvorak, H.F., Detmar, M., Claffey, K.P., Nagy, J.A., van de Water, L., and Senger, D.R., 1995, Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. Int Arch Allergy Immunol 107: 233–5.
Saebo, A., Kapperud, G., Lassen, J., and Waage, J., 1994, Prevalence of antibodies to Yersinia enterocolitica O:3 among Norwegian military recruits: association with risk factors and clinical manifestations. Eur J Epidemiol 10: 749–55.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Kluwer Academic Publishers
About this chapter
Cite this chapter
Saebo, A., Lassen, J. (2004). Vascular Endothelial Growth Factor in Yersiniosis. In: Skurnik, M., Bengoechea, J.A., Granfors, K. (eds) The Genus Yersinia. Advances in Experimental Medicine and Biology, vol 529. Springer, Boston, MA. https://doi.org/10.1007/0-306-48416-1_90
Download citation
DOI: https://doi.org/10.1007/0-306-48416-1_90
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-47759-1
Online ISBN: 978-0-306-48416-2
eBook Packages: Springer Book Archive